U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07338851) titled 'the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines' on Jan. 04.
Brief Summary: This study evaluated the antibody persistence of Chinese children five years after they received four doses of sIPV, two doses of MMR vaccine and one dose of HepA-L vaccine.
Study Start Date: Jan. 30
Study Type: OBSERVATIONAL
Condition:
Polio
Measles
Rubella
Mumps
Hepatitis A
Recruitment Status: NOT_YET_RECRUITING
Sponsor: China National Biotec Group Company Limited
Disclaimer: Curated by HT Syndication....